Skip to content

HEMOTECH BELUX

Active
Private limited companyfounded 200125 yrs activeBrouwerijstraat 14, 8680 Koekelare, BelgiumKBO/BCE: BE 0474.412.845
Summary

HEMOTECH BELUX has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €859,416 and a net result of €23,980. Equity is growing by ~27.3% per year across the filed fiscal years. Its solvency ranks better than 24% of 8741 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisWatch ReportCompare
HEMOTECH BELUXActiveChecked score 55/100
Risk analysis ReportCompare

Overview

What they do
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
#6 company by total assets in Koekelare, Wholesale and retail trade sector1 site
How big
€5.0mtotal assets 2025
Staff
10.6 FTE
Equity
€859,416
Profit
€23,980
Turnover not published (abridged schema)
Financially healthy?
55 Fair Checked score 2025
Bankruptcy chance 12 m
0.4%
Who decides
Parent
POLLET MEDICAL GROUP · 100%
Accounts 22 d early0 of 10 deeds read
Why 55- Higher-failure-rate sector- Weak solvency vs sector+ Long track record+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2025
55 / 100
Fair
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability55▲+6
Solvency42▼-2
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45,000 at 30 days acceptable
Liquidity tight (current ratio 1.28 against 1.28 in 2024; short-term debt: 68.6% and cash: 0% of total assets), and 82.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 25 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
17.3%
Return on assets
0.5%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 8741 sector peers (2025).
NBB · sector comparison
Position among 8741 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
22 d early
2024
3 d early
2023
5 d early
2022
3 d early
2021
31 d early
2020
31 d early
2019
31 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 27 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Back to profitnet €118,944

Key points

  • Caution: Result fell in 2025from €118,944 to €23,980 ▼ 79.8% View
  • Positive: Company by total assets in Koekelare, Wholesale and…in the Checked rankings #6 View
  • Controlled by POLLET MEDICAL GROUPultimately: POLLET GROUP 100% View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€5.0m
Profit
€23,980
Solvency
17.3%
Total assets▲ 14.8%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 09-07-2026Annual accounts filed
  2. 28-07-2025Annual accounts filed
  3. 31-12-2024Back to profit
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
26-03-2001
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?POLLET GROUP · 27 companies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure